Answer
Severe or recurrent headache, visual disturbances or tinnitus may indicate idiopathic intracranial hypertension during mesalazine treatment; discontinuing mesalazine should be considered if this condition occurs.
Sources for this answer
- Pentasa Slow Release Tablets 500mgFerring Pharmaceuticals Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 22Document updated
Sources checked